Compound Summary
Compound Name: | 2-Chloroadenosine |
Compound CID: | 8974 |
Synonyms: | 2-Chloroadenosine 146-77-0 6-Amino-2-chloropurine riboside ADENOSINE, 2-CHLORO- 5-Chloroformycin A More... |
Iupac Name: | (2R,3R,4S,5R)-2-(6-amino-2-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
InChI: | InChI=1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1 |
InChIKey: | BIXYYZIIJIXVFW-UUOKFMHZSA-N |
Canonical Smiles: | C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N |
Isomeric Smiles: | C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)N |
Molecular Weight: | 301.69 |
Molecular Formula: | C10H12ClN5O4 |
Molecular Weight: | 301.69 |
Molecular Formula: | C10H12ClN5O4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 20 |
Complexity: | 367 |
2-Chloroadenosine | 2-Chloroadenosine |
---|---|
2-Chloroadenosine |
146-77-0 |
6-Amino-2-chloropurine riboside |
ADENOSINE, 2-CHLORO- |
5-Chloroformycin A |
2-Chloroadenosinehemihydrate |
CADO |
UNII-7W7ZUG45G8 |
Cl-Ado |
(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
MLS000028365 |
7W7ZUG45G8 |
CHEMBL285819 |
103090-47-7 |
2-CADO |
MFCD00005734 |
(2R,3R,4S,5R)-2-(6-amino-2-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
SMR000058612 |
2 Chloroadenosine |
2-Chloro Adenosine |
2Cl-Ado |
EINECS 205-678-3 |
NSC 36896 |
BRN 0043957 |
2-Chloroado |
2-CI Adenosine |
2-chloro-adenosine |
2-chloro3hadenosine |
Opera_ID_460 |
REGID_for_CID_8974 |
GTPL372 |
4-26-00-03725 (Beilstein Handbook Reference) |
MLS001424176 |
MLS002153284 |
SCHEMBL104094 |
2-(6-Amino-2-chloro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol |
AMY2581 |
CHEBI:125640 |
DTXSID301017134 |
HMS2051B22 |
HMS2235K11 |
ZINC3875976 |
BDBM50009525 |
PDSP1_000569 |
PDSP1_000999 |
PDSP1_001209 |
PDSP2_000567 |
PDSP2_000983 |
PDSP2_001193 |
AKOS015896917 |
AKOS015995296 |
AM83941 |
CCG-101063 |
CS-W008344 |
HY-W008344 |
NC00313 |
(2R,3R,4S,5R)-2-(6-amino-2-chloro-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
NCGC00021540-03 |
NCGC00021540-04 |
NCGC00021540-05 |
NCGC00021540-06 |
NCGC00021540-11 |
AS-12085 |
2-Chloro-9-(beta-D-ribofuranosyl)adenine |
AB0066073 |
DB-005234 |
146C770 |
Q27071883 |
(2R,3R,4S,5R)-2-(6-Amino-2-chloro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol |
2-6-Amino-2-(2-cyclopentyl-ethylamino)-purin-9-yl-5-hydroxymethyl-tetrahydro-furan-3,4-diol |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | 19 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 19 | 1 | 1 |